On Friday, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)’s shares inclined 2.07% to $0.207.
Aeterna Zentaris Inc. (AEZS) declared it has reached its aim of recruiting 500 patients for its pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer. The trial is being conducted in over 120 sites in North America, Europe and Israel. The primary efficacy endpoint is improvement in overall survival.
Following its first pre‑specified interim analysis last April, a Data and Safety Monitoring Board recommended that the ZoptEC Phase 3 study continue as planned. A second interim analysis is predictable during Q4, 2015 at about 192 events, with the final analysis planned at an anticipated 384 events. The trial is predictable to be accomplished by the end of 2016.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health. The company’s product pipeline comprises MACRILEN, which accomplished the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer.
General Mills, Inc. (NYSE:GIS)’s shares dropped -0.28% to $56.92.
General Mills unveiled its line-up of new products set to debut this summer. Leading this collection is a host of new products to align with growing consumer interest in wellness, counting new Yoplait Plenti, Nature Valley Toasted Oats Muesli, and Annie’s organic soups.
General Mills, Inc. manufactures and markets branded consumer foods in the United States and internationally. It also supplies branded and unbranded food products to the foodservice and commercial baking industries. The company operates in three segments: U.S. Retail, International, and Convenience Stores and Foodservice. Its products comprise ready-to-eat cereals; convenient meals, counting meal kits, ethnic meals, pizza, soups, side dish mixes, frozen breakfast, and frozen entrees; snacks comprising grain, fruit, and savory snacks, in addition to nutrition bars and frozen hot snacks; refrigerated yogurt products; ice creams; baking mixes and ingredients; refrigerated and frozen dough products; and frozen and shelf-stable vegetable products. In addition, the company’s products comprise organic products, such as meal kits, granola bars, and cereal.
At the end of Friday’s trade, Citizens Financial Group Inc (NYSE:CFG)‘s shares dipped -1.13% to $26.15.
Citizens Financial Group, Inc. ( CFG) reports second quarter net income of $190 million, or $0.35 per diluted common share, contrast with second quarter 2014 net income of $313 million, or $0.56 per diluted common share. The second quarter of 2014 comprised of the benefit of a $180 million after-tax gain related to the Chicago Divestiture. Second quarter 2015 net income was down $19 million from first quarter 2015 net income of $209 million, and diluted EPS was down $0.03 from $0.38 in first quarter 2015. Second quarter 2015 results were reduced by $25 million after-tax, or $0.05 per diluted common share, related to net restructuring charges and special items, as compared to $6 million after-tax, or $0.01, in first quarter 2015, and a net $0.19 benefit in the second quarter 2014, as detailed in the Talk aboution of Results portion of this release. Second quarter 2015 Adjusted diluted EPS* of $0.40 compares with $0.39 in first quarter 2015 and $0.37 in second quarter 2014 given the impact of revenue growth initiatives, strong expense control, and continued favorable credit trends.
Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, N.A. and Citizens Bank of Pennsylvania that provide retail and commercial banking products and services in the United States. It operates through two segments, Consumer Banking and Commercial Banking. The Consumer Banking segment focuses on retail customers and small businesses with traditional banking products and services, counting checking, savings, home loans, student loans, credit cards, business loans, and financial administration services.
Manulife Financial Corporation (USA) (NYSE:MF), ended its Friday’s trading session with -0.63 loss, and closed at $17.44.
Manulife Financial Corporation declared that its U.S. Division (John Hancock Financial) has successfully accomplished its formerly declared reinsurance transaction through which New York Life has assumed, on a reinsurance basis, a net 60 percent interest in John Hancock’s in-force participating life insurance closed block, which was written prior to John Hancock’s demutualization in 2000. John Hancock will continue to service the policies and there will be no change in contract terms or policyholder benefits as a result of the reinsurance.
The reinsurance transaction was declared on December 23, 2014, together with a contract under which John Hancock would acquire New York Life’s Retirement Plan Services (RPS) business. The acquisition of the Retirement Plans Services business closed on April 14, 2015.
Manulife Financial Corporation, together with its auxiliaries, provides financial protection and wealth administration products and services to individual, corporate, and business customers primarily in Asia, Canada, and the United States. It offers various individual life and health insurance, and individual and group long-term care insurance products through insurance agents, brokers, banks, financial planners, and direct marketing.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
